Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
The Potential of Rosuvastatin and Candesartan to Retard the Progression of Aortic Stenosis (ROCK-AS)
This study is currently recruiting participants.
Study NCT00699452. Last updated on June 17, 2008.
Information provided by Helsinki University
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Aortic Valve Stenosis
Additional conditions recognized in this trial
Constriction, Pathologic
More general conditions related to this trial
Cardiovascular Diseases
Heart Diseases
Heart Valve Diseases
Pathological Conditions, Anatomical
Ventricular Outflow Obstruction
Interventions listed in this trial
rosuvastatin
candesartan
rosuvastatin and candesartan
placebo
Additional drug interventions recognized in this trial
Candesartan cilexetil
More general drug interventions related to this trial
Angiotensin II Type 1 Receptor Blockers
Anticholesteremic Agents
Antihypertensive Agents
Antilipemic Agents
Antimetabolites
Cardiovascular Agents
Enzyme Inhibitors
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Helsinki University
AstraZeneca
Back to top of Main Content